Literature DB >> 21934342

Significant elevation of survivin and livin expression in human colorectal cancer: inverse correlation between expression and overall survival.

Ren Chong Xi1, Wang Shou Biao, Zhang Zhi Gang.   

Abstract

BACKGROUND: Survivin and livin are novel members of the inhibitor of apoptosis protein family, which have rarely been studied in human colorectal cancer (CRC). This study aims to examine their expression and association with clinicopathological factors and prognosis in CRC, and evaluate the possibility of their use as biomarkers for CRC. PATIENTS AND METHODS: We investigated the expression of survivin and livin in 61 CRC samples using immunohistochemical staining (Envision) and correlated it with the survival of these patients using log-rank test and correlation analysis.
RESULTS: Among the 61 cases, 60.7 and 54.1% were positive for expression of survivin (p < 0.05) and livin (p < 0.05). No expression of survivin and livin was detected in normal colorectal mucosa. An inverse correlation (r = -0.9916) between the increased survivin and livin levels and overall survival was observed in univariate survival analysis. The expression of both proteins was not correlated with age, gender, degrees of differentiation, and TNM stage (p < 0.05) in malignancies.
CONCLUSIONS: High expression of both survivin and livin may influence the prognosis of CRC. This finding opens new perspectives for CRC prognosis because survivin and livin can both be used as biomarkers or potential therapeutic targets.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934342     DOI: 10.1159/000331132

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  16 in total

1.  Prognostic value of survivin in patients with non-Hodgkin's lymphoma: a meta-analysis.

Authors:  Chuan He; Zhigang Liu; Jie Ji; Huanling Zhu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients.

Authors:  Katarzyna Jakubowska; Anna Pryczynicz; Violetta Dymicka-Piekarska; Waldemar Famulski; Katarzyna Guzińska-Ustymowicz
Journal:  Oncol Lett       Date:  2016-09-01       Impact factor: 2.967

3.  Expression of survivin and its four splice variants in colorectal cancer and its clinical significances.

Authors:  Quan-Xing Ge; Yu-Yuan Li; Yu-Qiang Nie; Wen-Ge Zuo; Yan-Lei Du
Journal:  Med Oncol       Date:  2013-03-15       Impact factor: 3.064

4.  Expression of the apoptosis inhibitor livin in colorectal adenoma-carcinoma sequence: correlations with pathology and outcome.

Authors:  Y Wang; Y Li; B Zhou; W Y Zhang; J T Guan; R Wang; L Yang; Q J Xia; Z G Zhou; X F Sun
Journal:  Tumour Biol       Date:  2014-10-23

5.  Expression of AQP5 and AQP8 in human colorectal carcinoma and their clinical significance.

Authors:  Wei Wang; Qing Li; Tao Yang; Guang Bai; Dongsheng Li; Qiang Li; Hongzhi Sun
Journal:  World J Surg Oncol       Date:  2012-11-13       Impact factor: 2.754

6.  Expression of Livin in colorectal cancer and its relationship to tumor cell behavior and prognosis.

Authors:  Dae-Seong Myung; Young-Lan Park; Cho-Yun Chung; Hyung-Chul Park; Jong-Sun Kim; Sung-Bum Cho; Wan-Sik Lee; Kyung-Hwa Lee; Jae-Hyuk Lee; Young-Eun Joo
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

7.  Tafazzin protein expression is associated with tumorigenesis and radiation response in rectal cancer: a study of Swedish clinical trial on preoperative radiotherapy.

Authors:  Surajit Pathak; Wen-Jian Meng; Hong Zhang; Sebastian Gnosa; Suman Kumar Nandy; Gunnar Adell; Birgitta Holmlund; Xiao-Feng Sun
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

8.  Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients.

Authors:  Xiaochi Chen; Tiezheng Wang; Deyong Yang; Jianbo Wang; Xiancheng Li; Zhongzhou He; Feng Chen; Xiangyu Che; Xishuang Song
Journal:  Oncol Lett       Date:  2013-01-23       Impact factor: 2.967

9.  Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells.

Authors:  Zhitu Zhu; Enze Li; Yangyang Liu; Yu Gao; Hongzhi Sun; Guangyou Ma; Zhenghua Wang; Xiaomei Liu; Qingjun Wang; Xiujuan Qu; Yunpeng Liu; Yunlong Yu
Journal:  World J Surg Oncol       Date:  2012-10-30       Impact factor: 2.754

10.  Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis.

Authors:  Andreas Krieg; Thomas A Werner; Pablo E Verde; Nikolas H Stoecklein; Wolfram T Knoefel
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.